Evidence-Based Complementary and Alternative Medicine / 2015 / Article / Tab 2 / Research Article
Chinese Herbal Decoction Based on Syndrome Differentiation as Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer: An Exploratory and Small Prospective Cohort Study Table 2 ES-SCLC patient characteristics.
Characteristics Time of CHD treatment (months) First phase Second phase Total time >3 ( ) ≤3 ( ) >7 ( ) ≤7 ( ) >12 ( ) <12 ( ) Median age (range) 60 (42–75) 62 (47–74) 61 (55–70) 60 (42–74) 61 (47–70) 60 (42–74) Sex, (%) Men 11 (73) 11 (85) 10 (77) 11 (79) 11 (73) 11 (85) Women 4 (27) 2 (15) 3 (23) 3 (21) 4 (27) 2 (15) Smoking status index, (%) <400 3 (20) 3 (23) 2 (15) 4 (29) 4 (27) 2 (15) ≥400 9 (60) 8 (62) 9 (69) 7 (50) 9 (60) 8 (62) No history of smoking 3 (20) 2 (15) 2 (15) 3 (21) 2 (13) 3 (23) PS, (%) 1 7 (47) 6 (46) 9 (69) 7 (50) 8 (53) 6 (46) 2 8 (53) 7 (54) 4 (31) 7 (50) 7 (47) 7 (54) Site of metastasis, (%) Lung 6 (40) 9 (69) 7 (54) 8 (57) 7 (54) 8 (61) Distant lymph nodes 15 (100) 13 (100) 13 (100) 14 (100) 15 (100) 13 (100) Bone 2 (13) — 1 (8) 1 (7) 1 (7) 1 (8) Peritoneum 1 (7) 1 (8) 1 (8) 1 (7) 2 (13) — Pleura 1 (7) — 1 (8) — 1 (7) — Hydrothorax 1 (7) — 1 (8) — 1 (7) — Concomitant diseases, (%) Diabetes 5 (33) 3 (23) 4 (31) 4 (29) 8 (53) 3 (23) Hypertension 1 (7) 3 (23) 3 (23) 1 (7) 2 (13) 2 (15) Heart disease 1 (7) 1 (8) 2 (15) — 2 (13) — Effectiveness of chemotherapy response, (%) Complete response 2 (13) 2 (14) 4 (31) — 4 (27) — Partial response 7 (47) 8 (62) 7 (54) 7 (50) 11 (73) 4 (31) Stable disease 4 (27) 5 (38) 2 (15) 7 (50) — 9 (69) Radiotherapy, (%) 7 (47) 8 (62) 6 (46) 9 (64) 7 (47) 8 (61)